Molecular Tools to Identify Indolent Breast Cancers

This secondary analysis of data from a randomized clinical trial of women treated with tamoxifen vs no systemic therapy and followed up for 2 decades investigates if a multigene classifier is associated with indolent behavior of invasive breast cancers.

http://ift.tt/2t5gYRJ